Icon

SINEMET (nda017555)- (10MG;100MG,25MG;250MG,25MG;100MG)

CARBIDOPA; LEVODOPA ORGANON
10MG;100MG,25MG;250MG,25MG;100MG
No No
Expired Expired
None None
None No
SINEMET is indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
11 0 9
Total Other Developers 9
Drugs with Suitability Yes
10MG;100MG ** ** - - 7
25MG;250MG ** ** - - 7
25MG;100MG ** ** - - 7
NDA Sales Available Total Generic Sales Available
No 9
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** **** ** ***** ****** ************* *** ***. *********** **** **** ***** ****, ********* *****, ***** ********* ****, ********* (***) ***
****** ******* ********* **** ***** ********** *.*.* *********** ********* ***/**, *******, *****, *** **, ***** ******** (***) ***
****** *** ***** **** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** ***** ********** *** *** *********** ** ****** **, ****** ****, *** ****, ********* (***) ***
****** ******* ****** *** ******* ***************, ***. *********** ** ***** *****, *********, *** **** (**) *****-****, ****** ****** (***) ***
****** ******* ******* ******** ******* ******* *********** **** ** *-**/* & ***/*, ****, ********** ********* ****,, *****, *********** *** ***, ***** (***) ***
****** ********* ****** *** *** ********** ******* *********** ****-**, **** **.**, *****, *.*.***, ******** *******, ********* ******, ******** ********, ********, ****** ******* ******, ***** (***) ***
****** ***** ****** ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ** ****** **** ** ***** ****** ************* *** ***. *********** **** **** ***** ****, ********* *****, ***** ********* ****, ********* (***) ***
****** ** ****** **** ** ***** ****** ************* *** ***. *********** **** **** ***** ****, ********* *****, ***** ********* ****, ********* (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.